骨科患者服用克洛皮多格雷尔的低分子量肝素:一个集中审查
Ahmed Mohamed1, Abed Ullah Khan2, Usman Fuad1
1Trauma and Orthopaedics, Royal Cornwall Hospital, Truro, GBR.
Cureus
|November 13, 2025
概括
整形外科医生必须在患者需要克洛皮多格勒和低分子量肝素 (LMWH) 时平衡出血风险. 单独使用克洛皮多格雷尔是不会的.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 血栓形成的管理
背景情况:
- 整形外科医生经常治疗需要低分子量肝素 (LMWH) 进行静脉血栓预防的克洛皮多格雷尔患者.
- 管理双重抗血小板和抗凝药治疗具有显著的出血风险.
- 了解动脉和静脉血栓的独特机制对于适当的药物管理至关重要.
研究的目的:
- 审查动脉和静脉血栓症之间的差异.
- 为了阐明结合克洛皮多格勒和LMWH的必要性,尽管增加了出血风险.
- 提供基于证据的指导,在骨科手术中管理克洛皮多格雷尔和LMWH.
主要方法:
- 在PubMed,Cochrane图书馆,Embase和谷歌学者中进行全面的文献搜索 (2000年1月至2025年8月).
- 选了1184个记录,包括57个研究 (8个RCT,32个队列研究,17个系统审查).
- 由于研究异质性的结构化叙事合成;使用Cochrane偏差风险和纽卡斯尔-太华尺度进行质量评估.
主要成果:
- 克洛皮多格雷尔单独治疗不足以预防静脉血栓塞栓症 (VTE).
- 低分子量肝素 (LMWH) 对于固定骨科患者的静脉瘤预防仍然至关重要.
- 选择性骨科手术通常需要暂时停止使用克洛皮多格雷尔,而创伤手术管理不应因持续的克洛皮多格雷尔治疗而延迟.
结论:
- 需要LMWH的克洛皮多格雷尔患者的安全和有效管理需要仔细考虑血栓的类型和手术背景.
- 在选择性骨科手术中,一般建议暂停使用克洛皮多格雷尔.
- 在创伤环境中,持续使用克洛皮多格雷尔的好处可能超过风险,需要量身定制的管理策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Peripheral Artery Disease III: Interprofessional Care
231
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
231
Peripheral Artery Disease V: Postoperative Nursing Management
360
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
360


